Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Inamul Haque
Cyr61/Ccn1 Regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Deficiency of CCN5/WISP-2-Driven Program in Breast Cancer Promotes Cancer Epithelial Cells to Mesenchymal Stem Cells and Breast Cancer Growth
Scientific Reports
Multidisciplinary
Related publications
Development and in Vitro Characterization of a Gemcitabine-Loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
The Anti-Fibrotic Effect of GV1001 Combined With Gemcitabine on Treatment of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
Genes
Genetics
Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma
Frontiers in Oncology
Cancer Research
Oncology
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine
Scientific Reports
Multidisciplinary